News articles about Senomyx (NASDAQ:SNMX) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Senomyx earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned news stories about the specialty chemicals company an impact score of 45.6851850883598 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Several equities research analysts recently weighed in on SNMX shares. Zacks Investment Research raised Senomyx from a “sell” rating to a “hold” rating in a report on Wednesday, May 10th. Roth Capital set a $2.00 price target on Senomyx and gave the stock a “hold” rating in a report on Tuesday, May 2nd. Finally, ValuEngine downgraded Senomyx from a “sell” rating to a “strong sell” rating in a report on Friday, June 2nd. One equities research analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $2.67.
Shares of Senomyx (NASDAQ SNMX) traded up 1.35% during midday trading on Thursday, hitting $0.82. The company had a trading volume of 50,430 shares. The stock’s 50-day moving average price is $0.85 and its 200-day moving average price is $0.98. The company’s market cap is $38.96 million. Senomyx has a 12 month low of $0.78 and a 12 month high of $4.85.
Senomyx (NASDAQ:SNMX) last announced its quarterly earnings results on Friday, April 28th. The specialty chemicals company reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.01. Senomyx had a negative return on equity of 73.19% and a negative net margin of 55.06%. The company had revenue of $4.47 million during the quarter, compared to analyst estimates of $4.22 million. During the same quarter in the previous year, the firm posted ($0.05) EPS. The firm’s quarterly revenue was down 28.5% on a year-over-year basis. On average, equities research analysts forecast that Senomyx will post ($0.27) EPS for the current year.
Senomyx Company Profile
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.